These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12058352

  • 1. [beta-Adrenergic receptor blockers--a group of chiral drugs: different effects of each enantiomer].
    Cizmáriková R.
    Ceska Slov Farm; 2002 May; 51(3):121-8. PubMed ID: 12058352
    [Abstract] [Full Text] [Related]

  • 2. [Blockers of beta-adrenergic receptors--a group of chiral agents stereoselective synthesis of beta-blockers].
    Cizmáriková R, Valentová J, Hutt AJ, Sedláková S.
    Ceska Slov Farm; 2005 Sep; 54(5):201-6. PubMed ID: 16209433
    [Abstract] [Full Text] [Related]

  • 3. [Adrenergic beta-receptor blockers--a group of chiral drugs: enantioseparation in the group of beta-blockers].
    Cizmáriková R, Valentová J, Hutta JA.
    Ceska Slov Farm; 2004 Jan; 53(1):9-17. PubMed ID: 15065391
    [Abstract] [Full Text] [Related]

  • 4. Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis.
    Gagyi L, Gyéresi A, Kilár F.
    J Biochem Biophys Methods; 2008 Apr 24; 70(6):1268-75. PubMed ID: 18022245
    [Abstract] [Full Text] [Related]

  • 5. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K, Lindner W.
    Wien Med Wochenschr; 1990 Apr 15; 140(6-7):156-62. PubMed ID: 1971978
    [Abstract] [Full Text] [Related]

  • 6. Direct enantiomeric resolution of some cardiovascular agents using synthetic polymers imprinted with (-)-S-timolol as chiral stationary phase by thin layer chromatography.
    Aboul-Enein HY, el-Awady MI, Heard CM.
    Pharmazie; 2002 Mar 15; 57(3):169-71. PubMed ID: 11933843
    [Abstract] [Full Text] [Related]

  • 7. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R, Brocks DR.
    J Pharm Pharm Sci; 2001 Mar 15; 4(2):185-200. PubMed ID: 11466176
    [Abstract] [Full Text] [Related]

  • 8. Stereochemical comparison of nebivolol with other beta-blockers.
    Siebert CD, Hänsicke A, Nagel T.
    Chirality; 2008 Feb 15; 20(2):103-9. PubMed ID: 18072266
    [Abstract] [Full Text] [Related]

  • 9. Nonequivalence behavior studies for the direct determination of enantiomeric purity and absolute configuration of timolol by NMR.
    Hanna GM.
    Pharmazie; 2004 Dec 15; 59(12):923-8. PubMed ID: 15638079
    [Abstract] [Full Text] [Related]

  • 10. [The present status and prospects of therapeutic use of beta-blockers in diseases of the cardiovascular system].
    Kuzelová M, Svec P.
    Ceska Slov Farm; 1998 Feb 15; 47(1):4-9. PubMed ID: 9600149
    [Abstract] [Full Text] [Related]

  • 11. Enantioselective bioanalysis of beta-blocking agents: focus on atenolol, betaxolol, carvedilol, metoprolol, pindolol, propranolol and sotalol.
    Egginger G, Lindner W, Vandenbosch C, Massart DL.
    Biomed Chromatogr; 1993 Feb 15; 7(6):277-95. PubMed ID: 7905307
    [Abstract] [Full Text] [Related]

  • 12. Syntheses and beta-adrenergic binding affinities of (R)- and (S)-fluoronaphthyloxypropanolamines.
    Adejare A, Deal SA, Day MS.
    Chirality; 1999 Feb 15; 11(2):144-8. PubMed ID: 9951404
    [Abstract] [Full Text] [Related]

  • 13. Polymeric alkenoxy amino acid surfactants: II. Chiral separations of beta-blockers with multiple stereogenic centers.
    Rizvi SA, Akbay C, Shamsi SA.
    Electrophoresis; 2004 Mar 15; 25(6):853-60. PubMed ID: 15004846
    [Abstract] [Full Text] [Related]

  • 14. Biocatalytic approaches to optically active beta-blockers.
    Zelaszczyk D, Kieć-Kononowicz K.
    Curr Med Chem; 2007 Mar 15; 14(1):53-65. PubMed ID: 17266567
    [Abstract] [Full Text] [Related]

  • 15. Stereochemical facets of clinical β-blockers: An overview.
    Vashistha VK, Kumar A.
    Chirality; 2020 May 15; 32(5):722-735. PubMed ID: 32105373
    [Abstract] [Full Text] [Related]

  • 16. S-metoprolol: the 2008 clinical review.
    Dasbiswas A, Shinde S, Dasbiswas D.
    J Indian Med Assoc; 2008 Apr 15; 106(4):259-62. PubMed ID: 18828349
    [Abstract] [Full Text] [Related]

  • 17. Modeling, design, chiral aspects and role of para-substituents in aryloxypropranolamine based beta-blockers.
    Nandel FS, Dhaliwal RK, Singh B.
    Indian J Biochem Biophys; 1999 Feb 15; 36(1):29-35. PubMed ID: 10549157
    [Abstract] [Full Text] [Related]

  • 18. Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species?
    Gomes A, Costa D, Lima JL, Fernandes E.
    Bioorg Med Chem; 2006 Jul 01; 14(13):4568-77. PubMed ID: 16510286
    [Abstract] [Full Text] [Related]

  • 19. Update on beta blockers.
    Williams JR.
    AANA J; 1989 Feb 01; 57(1):29-36. PubMed ID: 2564714
    [Abstract] [Full Text] [Related]

  • 20. Biological significance of the enantiomeric purity of drugs.
    Waldeck B.
    Chirality; 1993 Feb 01; 5(5):350-5. PubMed ID: 8398592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.